Anixa Biosciences Stock Analysis

Anixa Stock Analysis Notes

About 18.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.39. Anixa Biosciences had not issued any dividends in recent years. The entity had 1:25 split on the 26th of June 2015. Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Anixa Biosciences please contact Amit Kumar at 408 708 9808 or go to https://www.anixa.com.

Anixa Biosciences Investment Alerts

Anixa Biosciences Upcoming and Recent Events

Anixa Largest EPS Surprises

View All Earnings Estimates

Anixa Biosciences Environmental, Social, and Governance (ESG) Scores

Anixa Stock Institutional Investors

Note, although Anixa Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anixa Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 101.74 M.

Anixa Profitablity

Management Efficiency

Anixa Biosciences has return on total asset (ROA) of (0.3842) % which means that it has lost $0.3842 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6261) %, meaning that it created substantial loss on money invested by shareholders. Anixa Biosciences' management efficiency ratios could be used to measure how well Anixa Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.7 in 2025. Return On Capital Employed is likely to drop to -0.87 in 2025. At this time, Anixa Biosciences' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 1.2 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 250.2 K in 2025.

Technical Drivers

As of the 23rd of March, Anixa Biosciences shows the Mean Deviation of 3.36, risk adjusted performance of 0.0577, and Downside Deviation of 4.18. Anixa Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Anixa Biosciences Price Movement Analysis

Anixa Biosciences Insider Trading Activities

Anixa Biosciences Outstanding Bonds

Anixa Biosciences Predictive Daily Indicators

Anixa Biosciences Corporate Filings

Anixa Biosciences Forecast Models

Anixa Biosciences' time-series forecasting models are one of many Anixa Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anixa Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anixa Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anixa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anixa Biosciences. By using and applying Anixa Stock analysis, traders can create a robust methodology for identifying Anixa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anixa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anixa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Anixa Biosciences stock analysis indicators help investors evaluate how Anixa Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anixa Biosciences shares will generate the highest return on investment. By understating and applying Anixa Biosciences stock analysis, traders can identify Anixa Biosciences position entry and exit signals to maximize returns.

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.